The spectrum of idiopathic pneumonia syndrome: Risk factors, diagnosis, and treatment

Clinical Pulmonary Medicine

Volumn 18, Issue 2, 2011, Pages 70-76

  Haddad, Imad Y ^a   Wiryawan, Budi ^a  

^a Banner Children's Hospital   (United States)

Author keywords

chemoradiotherapy; graft versus host disease; hematopoietic stem cell transplant; idiopathic pneumonia syndrome; tumor necrosis factor

Indexed keywords

AMINOCAPROIC ACID; ANTIBIOTIC AGENT; ANTICOAGULANT AGENT; ANTIFIBROTIC AGENT; BUSULFAN; CALCINEURIN INHIBITOR; CARMUSTINE; CISPLATIN; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; ETANERCEPT; IMMUNOSUPPRESSIVE AGENT; METHYLPREDNISOLONE; PREDNISONE; RECOMBINANT BLOOD CLOTTING FACTOR 7A; RITUXIMAB; STEROID; T LYMPHOCYTE ANTIBODY; THYMOCYTE ANTIBODY; TUMOR NECROSIS FACTOR ALPHA;

ACUTE GRAFT VERSUS HOST DISEASE; ADD ON THERAPY; ADENOVIRUS; ANTIBIOTIC THERAPY; ARTICLE; ASPERGILLUS; BRONCHIOLITIS OBLITERANS; BRONCHIOLITIS OBLITERANS ORGANIZING PNEUMONIA; BRONCHOSCOPY; CHEMORADIOTHERAPY; CHRONIC GRAFT VERSUS HOST DISEASE; COMPUTER ASSISTED TOMOGRAPHY; CONSERVATIVE TREATMENT; CONTINUOUS RENAL REPLACEMENT THERAPY; CORTICOSTEROID THERAPY; CYTOMEGALOVIRUS; DELAYED PULMONARY TOXICITY SYNDROME; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DIFFUSE ALVEOLAR HEMORRHAGE; DISEASE COURSE; DRUG DOSE REDUCTION; DRUG MEGADOSE; ENGRAFTMENT SYNDROME; FLUID RESUSCITATION; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IDIOPATHIC DISEASE; IDIOPATHIC PNEUMONIA SYNDROME; IMMUNOPATHOGENESIS; IMMUNOSUPPRESSIVE TREATMENT; INFLUENZA VIRUS; INTENSIVE CARE; INTERSTITIAL PNEUMONIA; LUNG BIOPSY; LUNG COMPLICATION; LUNG EDEMA; LUNG FUNCTION TEST; LUNG HEMODYNAMICS; LUNG HEMORRHAGE; LUNG INFECTION; LUNG LAVAGE; LUNG PARENCHYMA; LUNG TRANSPLANTATION; LYMPHOPROLIFERATIVE DISEASE; MESENCHYMAL STEM CELL; MULTIPOTENT STEM CELL; NONHUMAN; NONINVASIVE VENTILATION; NONMYELOABLATIVE CONDITIONING; PNEUMOCYSTIS JIROVECI; PNEUMONIA; POSTOPERATIVE COMPLICATION; POSTTRANSPLANT LYMPHOPROLIFERATIVE DISEASE; PROGNOSIS; PULMONARY CYTOLYTIC THROMBUS; PULMONARY VENO-OCCLUSIVE DISEASE; RADIATION DOSE; RESPIRATORY EPITHELIUM; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RISK FACTOR; SECOND CANCER; SEROLOGY; STEROID THERAPY; T LYMPHOCYTE; THORACOSCOPY; THORAX RADIOGRAPHY; THROMBUS; TREATMENT DURATION; TREATMENT PLANNING; VASCULAR ENDOTHELIUM;

EID: 79953155952     PISSN: 10680640     EISSN: None     Source Type: Journal    
DOI: 10.1097/CPM.0b013e31820e324c     Document Type: Article

References (47)

1. Huisman C, van der Straaten HM, Canninga-van Dijk MR, et al. Pulmonary complications after T-cell-depleted allogeneic stem cell transplantation: low incidence and strong association with acute graft-versus-host disease. Bone Marrow Transplant. 2006;38:561-566. (Pubitemid 44509549)
2. Sharma S, Nadrous HF, Peters SG, et al. Pulmonary complications in adult blood and marrow transplant recipients: autopsy findings. Chest. 2005;128:1385-1392. (Pubitemid 41324422)
3. Clark JG, Hansen JA, Hertz MI, et al. Idiopathic pneumonia syndrome after bone marrow transplantation. Am Rev Respir Dis. 1993;147:1601-1606. (Pubitemid 23160570)
4. Kantrow SP, Hackman RC, Boeckh M, et al. Idiopathic pneumonia syndrome: changing spectrum of lung injury after marrow transplantation. Transplantation. 1997;63:1079-1086. (Pubitemid 27190970)
5. Bilgrami SF, Metersky ML, McNally D, et al. Idiopathic pneumonia syndrome following myeloablative chemotherapy and autologous transplantation. Ann Pharmacother. 2001;35:196-201. (Pubitemid 32127130)
6. Kharbanda S, Panoskaltsis-Mortari A, Haddad IY, et al. Inflammatory cytokines and the development of pulmonary complications after allogeneic hematopoietic cell transplantation in patients with inherited metabolic storage disorders. Biol Blood Marrow Transplant. 2006;12:430-437. (Pubitemid 43380960)
7. Gupta S, Jain A, Warneke CL, et al. Outcome of alveolar hemorrhage in hematopoietic stem cell transplant recipients. Bone Marrow Transplant. 2007;40:71-78. (Pubitemid 47018416)
8. Wanko SO, Broadwater G, Folz RJ, et al. Diffuse alveolar hemorrhage: retrospective review of clinical outcome in allogeneic transplant recipients treated with aminocaproic acid. Biol Blood Marrow Transplant. 2006;12:949-953.
9. Capizzi SA, Kumar S, Huneke NE, et al. Peri-engraftment respiratory distress syndrome during autologous hematopoietic stem cell transplantation. Bone Marrow Transplant. 2001;27:1299-1303. (Pubitemid 32655399)
10. Maiolino A, Biasoli I, Lima J, et al. Engraftment syndrome following autologous hematopoietic stem cell transplantation: definition of diagnostic criteria. Bone Marrow Transplant. 2003;31:393-397. (Pubitemid 36410686)
11. Gorak E, Geller N, Srinivasan R, et al. Engraftment syndrome after nonmyeloablative allogeneic hematopoietic stem cell transplantation: incidence and effects on survival. Biol Blood Marrow Transplant. 2005;11:542-550. (Pubitemid 40862451)
12. Bhalla KS, Wilczynski SW, Abushamaa AM, et al. Pulmonary toxicity of induction chemotherapy prior to standard or high-dose chemotherapy with autologous hematopoietic support. Am J Respir Crit Care Med. 2000;161:17-25. (Pubitemid 30055897)
13. Wilczynski SW, Erasmus JJ, Petros WP, et al. Delayed pulmonary toxicity syndrome following high-dose chemotherapy and bone marrow transplantation for breast cancer. Am J Respir Crit Care Med. 1998;157:565-573. (Pubitemid 28090551)
14. McGaughey DS, Nikcevich DA, Long GD, et al. Inhaled steroids as prophylaxis for delayed pulmonary toxicity syndrome in breast cancer patients undergoing high-dose chemotherapy and autologous stem cell transplantation. Biol Blood Marrow Transplant. 2001;7:274-278. (Pubitemid 32591298)
15. Williams KM, Chien JW, Gladwin MT, et al. Bronchiolitis obliterans after allogeneic hematopoietic stem cell transplantation. JAMA. 2009;302:306-314.
16. Fukuda T, Boeckh M, Carter RA, et al. Risks and outcomes of invasive fungal infections in recipients of allogeneic hematopoietic stem cell transplants after nonmyeloablative conditioning. Blood. 2003;102:827-833. (Pubitemid 36917771)
17. Woodard JP, Gulbahce E, Shreve M, et al. Pulmonary cytolytic thrombi: a newly recognized complication of stem cell transplantation. Bone Marrow Transplant. 2000;25:293-300. (Pubitemid 30103019)
18. Fazekas T, Wiesbauer P, Kronberger M, et al. Nodular pulmonary lesions in children after autologous stem cell transplantation: a source of misinterpretation. Br J Haematol. 2008;140:429-432.
19. Montani D, Price LC, Dorfmuller P, et al. Pulmonary venoocclusive disease. Eur Respir J. 2009;33:189-200.
20. Stevens SJ, Verschuuren EA, Verkuujlen SA, et al. Role of Epstein-Barr virus DNA load monitoring in prevention and early detection of post-transplant lymphoproliferative disease. Leuk Lymphoma. 2002;43:831-840. (Pubitemid 34428672)
21. Shukla M, Yang S, Milla C, et al. Absence of host tumor necrosis factor receptor 1 attenuates manifestations of idiopathic pneumonia syndrome. Am J Physiol Lung Cell Mol Physiol. 2005;288: L942-L949. (Pubitemid 40547922)
22. Shankar G, Cohen DA. Idiopathic pneumonia syndrome after bone marrow transplantation: the role of pre-transplant radiation conditioning and local cytokine dysregulation in promoting lung inflammation and fibrosis. Int J Exp Pathol. 2001;82:101-113. (Pubitemid 32681937)
23. Cooke KR, Hill GR, Gerbitz A, et al. Hyporesponsiveness of donor cells to lipopolysaccharide stimulation reduces the severity of experimental idiopathic pneumonia syndrome: potential role for a gut-lung axis of inflammation. J Immunol. 2000;165:6612-6619.
24. Barloon TJ, Galvin JR, Mori M, et al. High-resolution ultrafast chest CT in the clinical management of febrile bone marrow transplant patients with normal or nonspecific chest roentgenograms. Chest. 1991;99:928-933.
25. Jain P, Sandur S, Meli Y, et al. Role of flexible bronchoscopy in immunocompromised patients with lung infiltrates. Chest. 2004;125:712-722. (Pubitemid 38223654)
26. Meersseman W, Lagrou K, Maertens J, et al. Galactomannan in bronchoalveolar lavage fluid: a tool for diagnosing aspergillosis in intensive care unit patients. Am J Respir Crit Care Med. 2008;177:27-34.
27. Gulbahce HE, Pambuccian SE, Jessurun J, et al. Pulmonary nodular lesions in bone marrow transplant recipients: impact of histologic diagnosis on patient management and prognosis. Am J Clin Pathol. 2004;121:205-210. (Pubitemid 38140124)
28. White DA, Wong PW, Downey R. The utility of open lung biopsy in patients with hematologic malignancies. Am J Respir Crit Care Med. 2000;161:723-729. (Pubitemid 30171723)
29. Paz HL, Crilley P, Weinar M, et al. Outcome of patients requiring medical ICU admission following bone marrow transplantation. Chest. 1993;104:527-531. (Pubitemid 23229528)
30. Afessa B, Tefferi A, Dunn WF, et al. Intensive care unit support and Acute Physiology and Chronic Health Evaluation III performance in hematopoietic stem cell transplant recipients. Crit Care Med. 2003;31:1715-1721. (Pubitemid 36714227)
31. Hilbert G, Gruson D, Vargas F, et al. Noninvasive ventilation in immunosuppressed patients with pulmonary infiltrates, fever, and acute respiratory failure. N Engl J Med. 2001;344:481-487. (Pubitemid 32164899)
32. Matthay MA, Uchida T, Fang X. Clinical acute lung injury and acute respiratory distress syndrome. Curr Treat Options Cardiovasc Med. 2002;4:139-149.
33. Wiedemann HP, Wheeler AP, Bernard GR, et al. Comparison of two fluid-management strategies in acute lung injury. N Engl J Med. 2006;354:2564-2575. (Pubitemid 43882352)
34. Flores FX, Brophy PD, Symons JM, et al. Continuous renal replacement therapy (CRRT) after stem cell transplantation. A report from the prospective pediatric CRRT Registry Group. Pediatr Nephrol. 2008;23:625-630.
35. Majhail NS, Parks K, Defor TE, et al. Diffuse alveolar hemorrhage and infection-associated alveolar hemorrhage following hematopoietic stem cell transplantation: related and high-risk clinical syndromes. Biol Blood Marrow Transplant. 2006;12:1038-1046. (Pubitemid 44597153)
36. Sanchez J, Torres A, Serrano J, et al. Long-term follow-up of immunosuppressive treatment for obstructive airways disease after allogeneic bone marrow transplantation. Bone Marrow Transplant. 1997;20:403-408. (Pubitemid 27390415)
37. Hino H, Kawatani E, Kuwahara N, et al. Successful treatment with intensive immunosuppressive therapy and mechanical ventilation for idiopathic pneumonia syndrome following allogeneic bone marrow transplantation. Rinsho Ketsueki. 2009;50:563-567.
38. Fukuda T, Hackman RC, Guthrie KA, et al. Risks and outcomes of idiopathic pneumonia syndrome after nonmyeloablative and conventional conditioning regimens for allogeneic hematopoietic stem cell transplantation. Blood. 2003;102:2777-2785. (Pubitemid 37248846)
39. Sampath S, Schultheiss TE, Wong J. Dose response and factors related to interstitial pneumonitis after bone marrow transplant. Int J Radiat Oncol Biol Phys. 2005;63:876-884. (Pubitemid 41400079)
40. Tomblyn M, Brunstein C, Burns LJ, et al. Similar and promising outcomes in lymphoma patients treated with myeloablative or nonmyeloablative conditioning and allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant. 2008;14:538-545. (Pubitemid 351494746)
41. Maloney D. Allogeneic transplantation following nonmyeloablative conditioning for aggressive lymphoma. Bone Marrow Transplant. 2008;42: S35-S36.
42. Rocha V, Broxymeyer H. New approaches for improving engraftment after cord blood transplantation. Biol Blood Marrow Transplant. 2010;16:5126-5132.
43. Ballen KK. New trends in umbilical cord blood transplantation. Blood. 2005;105:3786-3792. (Pubitemid 40656120)
44. Highfill SL, Kelly RM, O'Shaughnessy MJ, et al. Multipotent adult progenitor cells can suppress graft-versus-host disease via prostaglandin E2 synthesis and only if localized to sites of allopriming. Blood. 2009;114:693-701.
45. Yanik GA, Ho VT, Levine JE, et al. The impact of soluble tumor necrosis factor receptor etanercept on the treatment of idiopathic pneumonia syndrome after allogeneic hematopoietic stem cell transplantation. Blood. 2008;112:3073-3081.
46. Xu J, Woods CR, Mora AL, et al. Prevention of endotoxin-induced systemic response by bone marrow-derived mesenchymal stem cells in mice. Am J Physiol Lung Cell Mol Physiol. 2007;293: L131-L141. (Pubitemid 47080721)
47. Gupta N, Su X, Popov B, et al. Intrapulmonary delivery of bone marrow-derived mesenchymal stem cells improves survival and attenuates endotoxin-induced acute lung injury in mice. J Immunol. 2007;179:1855-1863.